{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:24:09Z","timestamp":1783376649640,"version":"3.54.6"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS09877202"],"award-info":[{"award-number":["NS09877202"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA04285202"],"award-info":[{"award-number":["DA04285202"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Effective treatment of high-impact pain patients is one of the major stated goals of the National Pain Strategy in the United States. Identification of new targets and mechanisms underlying neuropathic pain will be critical in developing new target-specific medications for better neuropathic pain management. We recently discovered that peripheral nerve injury-induced upregulation of an axonal guidance phosphoprotein collapsin response mediator protein 2 (CRMP2) and the N-type voltage-gated calcium (CaV2.2) as well as the NaV1.7 voltage-gated sodium channel, correlates with the development of neuropathic pain. In our previous studies, we found that interfering with the phosphorylation status of CRMP2 is sufficient to confer protection from chronic pain. Here we examined the expression of CRMP2 and CRMP2 phosphorylated by cyclin-dependent kinase 5 (Cdk5, on serine residue 522 (S522)) in sciatic nerve, nerve terminals of the glabrous skin, and in select subpopulations of DRG neurons in the SNI model of neuropathic pain. By enhancing our understanding of the phosphoregulatory status of CRMP2 within DRG subpopulations, we may be in a better position to design novel pharmacological interventions for chronic pain.<\/jats:p>","DOI":"10.1186\/s13041-020-00633-1","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T17:03:56Z","timestamp":1592845436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Differential expression of Cdk5-phosphorylated CRMP2 following a spared nerve injury"],"prefix":"10.1186","volume":"13","author":[{"given":"Aubin","family":"Moutal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya Sai","family":"Bellampalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9066-2969","authenticated-orcid":false,"given":"Rajesh","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"issue":"5","key":"633_CR1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.410330509","volume":"33","author":"JL Ochoa","year":"1993","unstructured":"Ochoa JL, Yarnitsky D. Mechanical hyperalgesias in neuropathic pain patients: dynamic and static subtypes. Ann Neurol. 1993;33(5):465\u201372.","journal-title":"Ann Neurol"},{"issue":"2","key":"633_CR2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1213\/00000539-198908000-00027","volume":"69","author":"I Kissin","year":"1989","unstructured":"Kissin I, Xavier AV, McDanal J. Blockade of sciatic nerve branches relieves sciatic radicular pain. Anesth Analg. 1989;69(2):262\u20133.","journal-title":"Anesth Analg"},{"issue":"4","key":"633_CR3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuron.2019.09.018","volume":"104","author":"M Calvo","year":"2019","unstructured":"Calvo M, Davies AJ, Hebert HL, Weir GA, Chesler EJ, Finnerup NB, et al. The genetics of neuropathic pain from model organisms to clinical application. Neuron. 2019;104(4):637\u201353.","journal-title":"Neuron."},{"issue":"12","key":"633_CR4","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1097\/j.pain.0000000000001002","volume":"158","author":"A Moutal","year":"2017","unstructured":"Moutal A, Yang X, Li W, Gilbraith KB, Luo S, Cai S, et al. CRISPR\/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide. Pain. 2017;158(12):2301\u201319.","journal-title":"Pain."},{"issue":"1","key":"633_CR5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/19336950.2017.1370524","volume":"12","author":"A Moutal","year":"2018","unstructured":"Moutal A, Cai S, Luo S, Voisin R, Khanna R. CRMP2 is necessary for Neurofibromatosis type 1 related pain. Channels (Austin). 2018;12(1):47\u201350.","journal-title":"Channels (Austin)"},{"key":"633_CR6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2018.04.002","volume":"381","author":"A Moutal","year":"2018","unstructured":"Moutal A, Sun L, Yang X, Li W, Cai S, Luo S, et al. CRMP2-Neurofibromin Interface drives NF1-related pain. Neuroscience. 2018;381:79\u201390.","journal-title":"Neuroscience."},{"issue":"14","key":"633_CR7","doi-asserted-by":"crossref","first-page":"9399","DOI":"10.1074\/jbc.M708206200","volume":"283","author":"S Patrakitkomjorn","year":"2008","unstructured":"Patrakitkomjorn S, Kobayashi D, Morikawa T, Wilson MM, Tsubota N, Irie A, et al. Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2. J Biol Chem. 2008;283(14):9399\u2013413.","journal-title":"J Biol Chem"},{"issue":"10","key":"633_CR8","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1007\/s12035-019-1568-4","volume":"56","author":"A Moutal","year":"2019","unstructured":"Moutal A, White KA, Chefdeville A, Laufmann RN, Vitiello PF, Feinstein D, et al. Dysregulation of CRMP2 post-translational modifications drive its pathological functions. Mol Neurobiol. 2019;56(10):6736\u201355.","journal-title":"Mol Neurobiol"},{"issue":"5","key":"633_CR9","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1007\/s12035-017-0653-9","volume":"55","author":"A Moutal","year":"2018","unstructured":"Moutal A, Villa LS, Yeon SK, Householder KT, Park KD, Sirianni RW, et al. CRMP2 phosphorylation drives Glioblastoma cell proliferation. Mol Neurobiol. 2018;55(5):4403\u201316.","journal-title":"Mol Neurobiol"},{"key":"633_CR10","doi-asserted-by":"crossref","unstructured":"Moutal A, Luo S, Largent-Milnes TM, Vanderah TW, Khanna R. Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain. Neurobiol Pain. 2019;5.","DOI":"10.1016\/j.ynpai.2018.07.003"},{"issue":"7","key":"633_CR11","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1007\/s12035-018-1445-6","volume":"56","author":"J Yu","year":"2019","unstructured":"Yu J, Moutal A, Dorame A, Bellampalli SS, Chefdeville A, Kanazawa I, et al. Phosphorylated CRMP2 regulates spinal nociceptive neurotransmission. Mol Neurobiol. 2019;56(7):5241\u201355.","journal-title":"Mol Neurobiol"},{"issue":"7","key":"633_CR12","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/j.pain.0000000000000555","volume":"157","author":"A Moutal","year":"2016","unstructured":"Moutal A, Chew LA, Yang X, Wang Y, Yeon SK, Telemi E, et al. (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology. Pain. 2016;157(7):1448\u201363.","journal-title":"Pain."},{"issue":"7","key":"633_CR13","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm.2345","volume":"17","author":"JM Brittain","year":"2011","unstructured":"Brittain JM, Duarte DB, Wilson SM, Zhu W, Ballard C, Johnson PL, et al. Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca (2)(+) channel complex. Nat Med. 2011;17(7):822\u20139.","journal-title":"Nat Med"},{"issue":"7","key":"633_CR14","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/j.pain.0000000000000147","volume":"156","author":"L Francois-Moutal","year":"2015","unstructured":"Francois-Moutal L, Wang Y, Moutal A, Cottier KE, Melemedjian OK, Yang X, et al. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors. Pain. 2015;156(7):1247\u201364.","journal-title":"Pain."},{"issue":"11","key":"633_CR15","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1097\/j.pain.0000000000001026","volume":"158","author":"A Moutal","year":"2017","unstructured":"Moutal A, Wang Y, Yang X, Ji Y, Luo S, Dorame A, et al. Dissecting the role of the CRMP2-neurofibromin complex on pain behaviors. Pain. 2017;158(11):2203\u201321.","journal-title":"Pain."},{"issue":"2","key":"633_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(00)00276-1","volume":"87","author":"I Decosterd","year":"2000","unstructured":"Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain. 2000;87(2):149\u201358.","journal-title":"Pain."},{"issue":"3","key":"633_CR17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1073\/pnas.0510405103","volume":"103","author":"TK Pareek","year":"2006","unstructured":"Pareek TK, Keller J, Kesavapany S, Pant HC, Iadarola MJ, Brady RO, et al. Cyclin-dependent kinase 5 activity regulates pain signaling. Proc Natl Acad Sci U S A. 2006;103(3):791\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"633_CR18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2006.08.008","volume":"127","author":"YR Yang","year":"2007","unstructured":"Yang YR, He Y, Zhang Y, Li Y, Li Y, Han Y, et al. Activation of cyclin-dependent kinase 5 (Cdk5) in primary sensory and dorsal horn neurons by peripheral inflammation contributes to heat hyperalgesia. Pain. 2007;127(1\u20132):109\u201320.","journal-title":"Pain."},{"issue":"14","key":"633_CR19","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/WNR.0000000000000237","volume":"25","author":"K Li","year":"2014","unstructured":"Li K, Zhao GQ, Li LY, Wu GZ, Cui SS. Epigenetic upregulation of Cdk5 in the dorsal horn contributes to neuropathic pain in rats. Neuroreport. 2014;25(14):1116\u201321.","journal-title":"Neuroreport."},{"issue":"2","key":"633_CR20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1523\/JNEUROSCI.0181-19.2019","volume":"40","author":"K Gomez","year":"2020","unstructured":"Gomez K, Calderon-Rivera A, Sandoval A, Gonzalez-Ramirez R, Vargas-Parada A, Ojeda-Alonso J, et al. Cdk5-dependent phosphorylation of CaV3.2 T-type channels: possible role in nerve ligation-induced neuropathic Allodynia and the compound action potential in primary afferent C fibers. J Neurosci. 2020;40(2):283\u201396.","journal-title":"J Neurosci"},{"issue":"2","key":"633_CR21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1073\/pnas.0609916104","volume":"104","author":"TK Pareek","year":"2007","unstructured":"Pareek TK, Keller J, Kesavapany S, Agarwal N, Kuner R, Pant HC, et al. Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1. Proc Natl Acad Sci U S A. 2007;104(2):660\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"633_CR22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10571-009-9483-2","volume":"30","author":"A Nair","year":"2010","unstructured":"Nair A, Simonetti M, Fabbretti E, Nistri A. The Cdk5 kinase downregulates ATP-gated ionotropic P2X3 receptor function via serine phosphorylation. Cell Mol Neurobiol. 2010;30(4):505\u20139.","journal-title":"Cell Mol Neurobiol"},{"issue":"45","key":"633_CR23","doi-asserted-by":"crossref","first-page":"17737","DOI":"10.1523\/JNEUROSCI.2049-13.2013","volume":"33","author":"X Zhang","year":"2013","unstructured":"Zhang X, Xin X, Dong Y, Zhang Y, Yu B, Mao J, et al. Surgical incision-induced nociception causes cognitive impairment and reduction in synaptic NMDA receptor 2B in mice. J Neurosci. 2013;33(45):17737\u201348.","journal-title":"J Neurosci"},{"issue":"22","key":"633_CR24","doi-asserted-by":"crossref","first-page":"12742","DOI":"10.1073\/pnas.211428098","volume":"98","author":"BS Li","year":"2001","unstructured":"Li BS, Sun MK, Zhang L, Takahashi S, Ma W, Vinade L, et al. Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc Natl Acad Sci U S A. 2001;98(22):12742\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"633_CR25","doi-asserted-by":"crossref","first-page":"E4462","DOI":"10.1073\/pnas.1700111114","volume":"114","author":"BTD Tobe","year":"2017","unstructured":"Tobe BTD, Crain AM, Winquist AM, Calabrese B, Makihara H, Zhao WN, et al. Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis. Proc Natl Acad Sci U S A. 2017;114(22):E4462\u2013E71.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"633_CR26","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2018.06.021","volume":"174","author":"A Zeisel","year":"2018","unstructured":"Zeisel A, Hochgerner H, Lonnerberg P, Johnsson A, Memic F, van der Zwan J, et al. Molecular architecture of the mouse nervous system. Cell. 2018;174(4):999\u20131014 e22.","journal-title":"Cell."},{"issue":"1","key":"633_CR27","first-page":"1","volume":"1","author":"A Moutal","year":"2016","unstructured":"Moutal A, Eyde N, Telemi E, Park KD, Xie JY, Dodick DW, et al. Efficacy of (S)-Lacosamide in preclinical models of cephalic pain. Pain Rep. 2016;1(1):1\u201310.","journal-title":"Pain Rep"},{"key":"633_CR28","doi-asserted-by":"crossref","unstructured":"Moutal A, Eyde N, Telemi E, Park KD, Xie JY, Dodick DW, et al. Efficacy of (S)-Lacosamide in preclinical models of cephalic pain. Pain Rep. 2016;1(1).","DOI":"10.1097\/PR9.0000000000000565"},{"issue":"3","key":"633_CR29","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s12035-015-9141-2","volume":"53","author":"A Moutal","year":"2016","unstructured":"Moutal A, Francois-Moutal L, Perez-Miller S, Cottier K, Chew LA, Yeon SK, et al. (S)-Lacosamide binding to Collapsin response mediator protein 2 (CRMP2) regulates CaV2.2 activity by subverting its phosphorylation by Cdk5. Mol Neurobiol. 2016;53(3):1959\u201376.","journal-title":"Mol Neurobiol"},{"key":"633_CR30","first-page":"196","volume":"8","author":"SM Wilson","year":"2014","unstructured":"Wilson SM, Moutal A, Melemedjian OK, Wang Y, Ju W, Francois-Moutal L, et al. The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth. Front Cell Neurosci. 2014;8:196.","journal-title":"Front Cell Neurosci"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-020-00633-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-020-00633-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-020-00633-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T23:34:34Z","timestamp":1624318474000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-020-00633-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["633"],"URL":"https:\/\/doi.org\/10.1186\/s13041-020-00633-1","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"6 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}